Eli Lilly’s Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.
The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available
by | Jul 23, 2026 | Uncategorized | 0 comments
Recent Comments